UTMD - Latest News

Utah Medical Products, Inc. (UTMD), operates in Healthcare / Medical - Instruments & Supplies, trades on NASDAQ.

Market capitalization stands near $205.4M. Trailing twelve-month P/E ratio is 18.94. Beta to the broader market is 0.37.

The article list below shows the most recent UTMD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent UTMD Headlines

Utah Medical Products, Inc. Announces Quarterly Dividend

accessnewswire.com - May 5, 2026

SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quart

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

zacks.com - Apr 29, 2026

UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved ma

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026

accessnewswire.com - Apr 23, 2026

SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attaine

Head-To-Head Comparison: Utah Medical Products (NASDAQ:UTMD) and INLIF (NASDAQ:INLF)

defenseworld.net - Apr 18, 2026

Utah Medical Products (NASDAQ: UTMD - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both small-cap medical companies, but which is t

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

zacks.com - Apr 16, 2026

UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal

How News Affects UTMD Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track UTMD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked UTMD news questions

What is the latest UTMD news headline?

The most recent UTMD headline (May 5, 2026) is "Utah Medical Products, Inc. Announces Quarterly Dividend". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the UTMD news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What UTMD news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual UTMD options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.